Sasol (SOL) Stock Overview
Operates as a chemical and energy company. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
SOL Community Fair Values
Create NarrativeSee what 166 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Sasol Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R224.72 |
| 52 Week High | R242.00 |
| 52 Week Low | R67.69 |
| Beta | -0.24 |
| 1 Month Change | 16.16% |
| 3 Month Change | 83.52% |
| 1 Year Change | 225.30% |
| 3 Year Change | -3.58% |
| 5 Year Change | 2.08% |
| Change since IPO | 1,149.81% |
Recent News & Updates
Narrative Update • May 16
SOL: Lower Margins And Sales Guidance Will Pressure Future P/E
Analysts have lifted their Sasol price target from ZAR151.63 to ZAR155.00, citing updated assumptions around discount rates, revenue trends, profit margins and a higher future P/E multiple. What's in the News Sasol confirmed guidance for fiscal 2026 sales volumes, with most metrics unchanged compared with fiscal 2025 levels (company guidance).Narrative Update • Apr 30
SOL: Severe EPS Collapse Will Undermine Higher Margin Outlook And Future P/E Assumptions
Analysts have raised their price target for Sasol from ZAR117.00 to approximately ZAR151.63, reflecting updated assumptions that include a slightly lower discount rate, revised revenue expectations, higher profit margin forecasts, and a higher future P/E multiple. What's in the News Updated fiscal year 2026 guidance keeps most targets unchanged.Recent updates
Narrative Update • May 16
SOL: Lower Margins And Sales Guidance Will Pressure Future P/E
Analysts have lifted their Sasol price target from ZAR151.63 to ZAR155.00, citing updated assumptions around discount rates, revenue trends, profit margins and a higher future P/E multiple. What's in the News Sasol confirmed guidance for fiscal 2026 sales volumes, with most metrics unchanged compared with fiscal 2025 levels (company guidance).Narrative Update • Apr 30
SOL: Severe EPS Collapse Will Undermine Higher Margin Outlook And Future P/E Assumptions
Analysts have raised their price target for Sasol from ZAR117.00 to approximately ZAR151.63, reflecting updated assumptions that include a slightly lower discount rate, revised revenue expectations, higher profit margin forecasts, and a higher future P/E multiple. What's in the News Updated fiscal year 2026 guidance keeps most targets unchanged.
Narrative Update • Apr 16
SOL: Higher Margins And Weaker Near Term EPS Will Shape Future Rerating
Analysts have lifted their price target on Sasol from ZAR175.84 to ZAR222.00, citing updated assumptions that include a lower discount rate, a changed revenue growth outlook, higher expected profit margins and a revised future P/E multiple. What's in the News Sasol issued revenue guidance for the six months ended 31 December 2025, focusing on expected earnings per share for the period.Narrative Update • Apr 01
SOL: Severe EPS Collapse Will Weigh On Long-Term Bio-Circular Surfactant Story
Analysts have lifted their fair value estimate for Sasol from ZAR82 to ZAR117, citing updated assumptions for discount rates, revenue growth, profit margins, and future P/E levels. What's in the News Sasol issued earnings guidance for the six months ending 31 December 2025, focusing on expected earnings per share rather than providing a revenue range.
Narrative Update • Mar 18
SOL: EPS Collapse Guidance Will Undermine Confidence In Future Earnings Sustainability
Analysts have revised their fair value estimate for Sasol from ZAR122.44 to ZAR149.78, citing updated assumptions on discount rate, revenue growth, profit margin and future P/E as the key drivers of the new price target. What's in the News Sasol issued revenue guidance for the six months ended 31 December 2025, including an EPS range of ZAR0.10 to ZAR0.80 per share, compared with prior period EPS of ZAR7.22.Narrative Update • Mar 04
SOL: EPS Collapse Guidance Will Undermine Confidence In Higher Future Margins
Analysts have trimmed their Sasol price target slightly to ZAR122.44 from ZAR124.24, reflecting updated assumptions on discount rates, modestly higher revenue growth, stronger profit margins and a lower future P/E multiple. What's in the News Sasol issued revenue guidance for the six months ending 31 December 2025, including an earnings per share (EPS) range of ZAR0.10 to ZAR0.80 per share.Narrative Update • Feb 18
SOL: Severe EPS Guidance Will Weigh On Long-Term Bio-Circular Surfactant Story
Analysts have reduced their price target for Sasol from ZAR107 to ZAR82, citing revised assumptions that include a lower revenue growth outlook, a higher projected profit margin, a reduced discount rate and a lower future P/E multiple. What's in the News Sasol issued revenue guidance for the six months ending 31 December 2025, with expected EPS in a range of ZAR0.10 to ZAR0.80 per share.Narrative Update • Feb 04
SOL: Higher Margins And Lower Risk Profile Will Drive Future Upside
Analysts have adjusted their price expectations for Sasol, with the fair value estimate moving from R131.11 to R124.24 as they factor in updated assumptions for revenue growth, profit margins and future P/E multiples. Valuation Changes Fair Value Estimate: reduced slightly from R131.11 to R124.24, reflecting updated assumptions in the model.Analysis Article • Jan 25
There's Been No Shortage Of Growth Recently For Sasol's (JSE:SOL) Returns On Capital
What trends should we look for it we want to identify stocks that can multiply in value over the long term? In a...Narrative Update • Jan 20
SOL: Higher Profit Margin Outlook Will Support Bullish Long Term rerating
Sasol's updated analyst price target is now set around R175.84, a small move from the prior R175.22. Analysts cited revised assumptions for discount rates, revenue growth, profit margins and future P/E as the basis for this fine tuning.Narrative Update • Jan 06
SOL: Bio-Circular Surfactants Will Support A Steady And Balanced Long-Term Outlook
Analysts kept their fair value estimate for Sasol steady at R107, with small tweaks to discount rate, revenue growth and profit margin assumptions supporting the unchanged price target. Valuation Changes Fair Value: Kept unchanged at R107.00 per share, reflecting the updated set of assumptions.Analysis Article • Dec 29
Sasol (JSE:SOL) Use Of Debt Could Be Considered Risky
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Narrative Update • Dec 19
SOL: Bio-Circular Surfactants Will Support A More Balanced Long-Term Outlook
Analysts have raised their price target on Sasol from approximately $70 to $107 per share, citing a higher assumed future earnings multiple that more than offsets adjusted expectations for revenue growth and profit margins. What's in the News Sasol International Chemicals has launched LIVINEX IO 7, a patent-pending bio-circular surfactant derived from insect oils, positioned as a first of its kind in fabric, home care, industrial and institutional cleaning markets (Key Developments).Narrative Update • Dec 05
SOL: Lower Risk Profile And Bio Circular Surfactants Will Drive Future Upside
Analysts have nudged their price target for Sasol slightly higher, from R130.78 to R131.11. This reflects a modestly lower perceived risk via a reduced discount rate, which more than offsets slightly softer assumptions for long term revenue growth and profit margins.Analysis Article • Nov 17
Sasol Limited's (JSE:SOL) Shares Bounce 26% But Its Business Still Trails The Industry
Sasol Limited ( JSE:SOL ) shareholders would be excited to see that the share price has had a great month, posting a...Narrative Update • Oct 31
SOL: Surfactant Commercialization And Higher Margins Will Drive Future Performance
Analysts have revised their price target for Sasol downward from R134.11 to R130.78, citing slightly increased discount rates even though revenue growth and profit margin forecasts have improved. What's in the News Sasol International Chemicals has launched and commercialized LIVINEX IO 7, a bio-circular, palm and deforestation-free surfactant made from insect oils (Key Developments).Analysis Article • Oct 14
Sasol (JSE:SOL) Is Experiencing Growth In Returns On Capital
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...Analysis Article • Sep 23
Sasol (JSE:SOL) Has A Somewhat Strained Balance Sheet
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...Analysis Article • Sep 01
Why Sasol's (JSE:SOL) Earnings Are Better Than They Seem
Investors signalled that they were pleased with Sasol Limited's ( JSE:SOL ) most recent earnings report. This reaction...Narrative Update • Aug 28
Renewable Energy And Specialty Chemicals Will Fuel Future Success
Sasol’s valuation outlook is essentially unchanged, as both the discount rate and future P/E saw only marginal adjustments, leaving the consensus analyst price target steady at ZAR123.56. What's in the News Sasol Limited expects EPS for the fiscal year ended June 2025 to increase by over 20% versus the prior year's loss per share of ZAR 69.94, which was heavily affected by negative remeasurement items of ZAR 88.13 per share (Key Developments).Analysis Article • Aug 26
Further Upside For Sasol Limited (JSE:SOL) Shares Could Introduce Price Risks After 35% Bounce
Despite an already strong run, Sasol Limited ( JSE:SOL ) shares have been powering on, with a gain of 35% in the last...Analysis Article • May 27
There's No Escaping Sasol Limited's (JSE:SOL) Muted Revenues Despite A 28% Share Price Rise
Sasol Limited ( JSE:SOL ) shareholders are no doubt pleased to see that the share price has bounced 28% in the last...Analysis Article • May 22
There's Been No Shortage Of Growth Recently For Sasol's (JSE:SOL) Returns On Capital
Did you know there are some financial metrics that can provide clues of a potential multi-bagger? One common approach...
New Narrative • Feb 09
Streamlined Operations And Renewable Energy Projects Will Improve Future Efficiency
Streamlining operations, restructuring roles, and focusing on core business could enhance efficiency, accountability, and earnings through improved margins and cash generation.Shareholder Returns
| SOL | ZA Chemicals | ZA Market | |
|---|---|---|---|
| 7D | 5.5% | 3.6% | -2.5% |
| 1Y | 225.3% | 98.5% | 20.0% |
Return vs Industry: SOL exceeded the ZA Chemicals industry which returned 98.5% over the past year.
Return vs Market: SOL exceeded the ZA Market which returned 20% over the past year.
Price Volatility
| SOL volatility | |
|---|---|
| SOL Average Weekly Movement | 11.4% |
| Chemicals Industry Average Movement | 5.6% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in ZA Market | 10.9% |
| 10% least volatile stocks in ZA Market | 3.3% |
Stable Share Price: SOL's share price has been volatile over the past 3 months compared to the ZA market.
Volatility Over Time: SOL's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of ZA stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1950 | 27,107 | Simon Baloyi | www.sasol.com |
Sasol Limited operates as a chemical and energy company. It offers bitumen, industrial heating fuels, naphtha, lubricants and lubricant base oils, liquefied petroleum gas, automotive and industrial lubricants, greases, cleansers and degreasers, automotive fuels, and burner fuels or domestic, as well as illuminating paraffin transport fuels, such as petrol, diesel, and jet fuels. The company also provides methane rich and natural gas.
Sasol Limited Fundamentals Summary
| SOL fundamental statistics | |
|---|---|
| Market cap | R144.43b |
| Earnings (TTM) | R2.41b |
| Revenue (TTM) | R249.38b |
60.2x
P/E Ratio0.6x
P/S RatioIs SOL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SOL income statement (TTM) | |
|---|---|
| Revenue | R249.38b |
| Cost of Revenue | R147.96b |
| Gross Profit | R101.42b |
| Other Expenses | R99.02b |
| Earnings | R2.41b |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.73 |
| Gross Margin | 40.67% |
| Net Profit Margin | 0.97% |
| Debt/Equity Ratio | 59.7% |
How did SOL perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/17 15:37 |
| End of Day Share Price | 2026/05/15 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sasol Limited is covered by 15 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Gerhard Engelbrecht | Absa Bank Limited |
| Jared Hoover | Arqaam Capital Research Offshore S.A.L. |
| Caroline Learmonth | Barclays |